Another in vitro study indicated that ATRA blocked the activation of Nrf2 by activating the RARα–Nrf2 complex, rendering ROS accumulation and ROS-dependent cytotoxicity in MDS and AML cells when combined with DAC [228]. Here, NFE2L2 is linked to myelodysplastic syndrome.